The Veterinary Medicines Regulations 2013

Time limits for marketing authorisations granted under the procedure for a [F3generic veterinary medicinal] productE+W+S

This section has no associated Explanatory Memorandum

11.—(1) This paragraph establishes the time limits relating to granting a marketing authorisation under the procedure for a [F4generic veterinary medicinal] product.

(2) An application for a marketing authorisation cannot be made until two years before the product may be placed on the market in accordance with this paragraph.

[F5(3) The product may not be placed on the market until the end of the longest of the following periods which is relevant—

(a)subject to sub-paragraph (3A), 10 years in the case of a veterinary medicinal product authorised for major species;

(b)18 years in the case of a veterinary medicinal product authorised for bees; and

(c)14 years for a veterinary medicinal product authorised for all other species.

(3A) Where the product—

(a)is intended for administration to a major species; and

(b)contains an active substance which is an antimicrobial which has not been an active substance in a veterinary medicinal product previously subject to a marketing authorisation in Great Britain,

the period mentioned in sub-paragraph (3)(a) is 14 years.

(3B) Where a patent in relation to a reference product has lapsed, the summary of product characteristics of the relevant generic product must be updated in order to include the protected information.

(3C) Where, as a result of a variation to an existing marketing authorisation a product is accorded a new marketing authorisation number any relevant protection period applies in relation to that product.

(3D) In this regulation “major species” means cattle, sheep (for meat production), pigs, chickens, dogs and cats.]

(4) Time limits in this paragraph are calculated from the first grant of the marketing authorisation for the reference product.

Textual Amendments

Time limits for marketing authorisations granted under the procedure for a pharmacologically equivalent productN.I.

11.—(1) This paragraph establishes the time limits relating to granting a marketing authorisation under the procedure for a pharmacologically equivalent product.

(2) An application for a marketing authorisation cannot be made until two years before the product may be placed on the market in accordance with this paragraph.

(3) The product may not be placed on the market until ten years (or, in the case of medicinal products for fish or bees where the application for a marketing authorisation was submitted after 30th October 2005, thirteen years) have elapsed from the initial authorisation of the reference product.

(4) Time limits in this paragraph are calculated from the first grant of the marketing authorisation for the reference product.